Prazosin Hydrochloride Capsule shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting Apr 28, 2023 · last update Apr 28, 2023
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Minipress, Capsule, 1 mg (NDC 0069-4310-71) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023 | Posted Apr 28, 2023 Updated Apr 28, 2023 Discontinued Apr 28, 2023 |
| Minipress, Capsule, 2 mg (NDC 0069-4370-71) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023 | Posted Apr 28, 2023 Updated Apr 28, 2023 Discontinued Apr 28, 2023 |
| Minipress, Capsule, 5 mg (NDC 0069-4380-71) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023 | Posted Apr 28, 2023 Updated Apr 28, 2023 Discontinued Apr 28, 2023 |